Sarah Bly

Sarah Bly

Sarah Bly is Director Regulatory Science Strategy and Innovation at Worldwide Clinical Trials, UK

  • wheelchair professional

    A regulatory lens on an industry imperative: Diversity in clinical research


    Although clinical research is evolving alongside new technological advances, the inclusion of diverse populations within clinical trials has been slow. Regulatory professionals are essential stakeholders in the quest for ensuring inclusivity of these groups…

  • AdobeStock_269493370
    Meeting Report

    HM10: Scenarios to Consider Risk


    This interactive session focused on how to develop and successfully implement a regulatory strategy. Participants were given the opportunity to analyse different scenarios and compare answers with the panellists who provided practical advice on ways to avoid potential pitfalls and disastrous mistakes.